Cargando…
Low-Dose Immunotherapy: Is It Just an Illusion?
The development and use of immunotherapy in the last decade have led to a drastic improvement in results in the onco-haematological field. This has implied, on the one hand, the need for clinicians to manage a new type of adverse event and, on the other hand, a significant increase in costs. However...
Autores principales: | Meriggi, Fausto, Zaniboni, Alberto, Zaltieri, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136204/ https://www.ncbi.nlm.nih.gov/pubmed/37189650 http://dx.doi.org/10.3390/biomedicines11041032 |
Ejemplares similares
-
‘The same old story’: thoughts on authorized doses of anticancer
drugs
por: Meriggi, Fausto, et al.
Publicado: (2020) -
Illusions of techno-nationalism
por: Luo, Yadong
Publicado: (2021) -
Low-dose irradiation for reversing immunotherapy resistance: how to translate?
por: Ochoa-de-Olza, Maria, et al.
Publicado: (2022) -
Career decisions and gender: the illusion of choice?
por: Hill, Elspeth J. R., et al.
Publicado: (2014) -
BCG vaccination and COVID-19: Was flattening the curve just an illusion?
por: Ricco’, M., et al.
Publicado: (2021)